In February 2026, Labcorp announced nationwide availability of the Elecsys pTau-181 blood test, the first FDA-cleared primary-care tool to aid in ruling out Alzheimer’s disease by identifying ...

Labcorp is now offering Roche Diagnostics' recently FDA-cleared Alzheimer’s disease blood test to help primary care doctors ...

Labcorp Holdings Inc. LH, or Labcorp, is slated to report its fourth-quarter 2025 results on Feb. 17, before the market opens. The renowned laboratory service provider reported adjusted earnings of $4 ...

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the nationwide availability of the Elecsys® pTau-181 test, the first and only blood test ...

The company struck three deals in New York last year as part of its push to acquire hospital and regional testing labs.

Labcorp is a global life sciences company headquartered in Burlington, North Carolina. Labcorp provides at-home test kits as well as in-person testing at their laboratory facilities, which are located ...

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain ...

Labcorp continues its Northeast push through a multi-year partnership with SOMOS, one of New York's largest independent ...

Shares of Labcorp Holdings Inc. LH slipped 1.15% to $274.01 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.47% to 6,964.

Labcorp took a series of steps to expand in New York last year. In October, the company disclosed deals to buy assets from Empire City and Laboratory Alliance of Central New York, a pathology ...